StreetAlpha.app
Home › Stocks › CORT

Corcept Therapeutics Inc (CORT)

Healthcare
$63.62
▼ −2.09%
LAST CLOSE · NOV 20

Corcept Therapeutics sells Korlym for hypercortisolism and develops other drugs that act on the hormone cortisol. It last closed at $63.62 on Nov 20, down 2.09% on the day. The next earnings report for CORT is expected around Tue, Feb 23, 2027, after the close. For the quarter ended Sep 2026, CORT reported EPS of $1.01 on revenue of $340.5M, with revenue up 64.0% from a year ago. Over its last 8 reports the stock moved an average of 7.8% the session after earnings. Over the last 12 months CORT insiders bought $3.3M of stock on the open market and sold $98.4M, according to SEC Form 4 filings.

AI Auto Pilots
Is CORT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CORT.

Key Stats

Last 12 months
Results
Revenue
$963.6M
+30.0% vs a year ago
Net income
$162.3M
+52.9% vs a year ago
EPS (diluted)
$1.33
+52.9% vs a year ago
Free cash flow
$194.6M
20.2% margin
Valuation
Market cap
$7.0B
109.4M shares
P/E
47.8
Price over 12 month EPS
Price to sales
7.2
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$98.7M
At Sep 30
Shareholder equity
$833.7M
Buybacks
$5.7M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $366.0M$366.0MFY2021FY2022: $401.9M$401.9MFY2022FY2023: $482.4M$482.4MFY2023FY2024: $675.0M$675.0MFY2024FY2025: $761.4M$761.4MFY2025

From CORT's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 3). Last 12 months adds up the four latest quarters.

Next report
Feb 23
Estimated date · After the close
Reported EPS
$1.01
Quarter ended Sep 2026
Year ago EPS
$0.16
+531.3% on a GAAP basis
Revenue
$340.5M
+64.0% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.25Dec '24Mar 2025: $0.17Mar '25Jun 2025: $0.29Jun '25Sep 2025: $0.16Sep '25Dec 2025: $0.20Dec '25Mar 2026: -$0.30Mar '26Jun 2026: $0.36Jun '26Sep 2026: $1.01Sep '26Latest $1.01
Revenue by quarter
Dec 2024: $181.9MDec '24Mar 2025: $157.2MMar '25Jun 2025: $194.4MJun '25Sep 2025: $207.6MSep '25Dec 2025: $202.1MDec '25Mar 2026: $164.9MMar '26Jun 2026: $256.1MJun '26Sep 2026: $340.5MSep '26Latest $340.5M
How CORT moved after its last 8 reports
Average move the session after a report ±7.8%
Nov 3, 2026After the close−3.3%
Jul 29, 2026After the close+27.3%
Apr 30, 2026After the close+10.5%
Feb 24, 2026After the close−0.7%
Nov 4, 2025After the close+7.8%
Jul 31, 2025After the close+2.7%
May 5, 2025After the close−4.3%
Feb 26, 2025After the close−5.5%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on CORTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on CORT
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on CORT

Technical Analysis

CORT · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, oversold

The stock is 19% below its 20 day and 56% below its 50 day average. It is 21% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 21), oversold. The nearest support is the Pivot S1 at $62.58, and the nearest resistance the Pivot at $63.85.

Short trendBearish
Long trendBullish
MomentumWeak
StretchOversold
VolatilityHigh, 7.7%/day
Key levels
$126.3852 week high+98.6%
$102.62100 day average+61.3%
$99.0350 day average+55.7%
$85.40Swing high (Jun 17)+34.2%
$77.18200 day average+21.3%
$75.9720 day average+19.4%
$64.90Pivot R1+2.0%
$63.85Pivot+0.4%
$63.62Last close
$62.58Pivot S1−1.6%
$28.6652 week low−55.0%
Indicators
RSI (14)20.93Oversold below 30Oversold
MACD-9.80Below its signal lineBearish
Stochastic3.5Near the bottom of its rangeOversold
ADX (14)52.2Strong downtrend
Williams %R-96.3Oversold below −80, overbought above −20Oversold
CCI (20)-136.7Oversold below −100, overbought above 100Oversold
Rate of change−12.6%Change over 10 sessionsBearish
ATR (14)$4.87Typical daily range, 7.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CORT

What happened before

See how CORT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow CORT usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How CORT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for CORTHow many large options trades hit CORT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

CORT Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲288 buying vs 188 selling
  • ▼Held by funds -2.0 pts
  • ▲Funds holding +79
  • ▲Superinvestors: 2 added, 1 cut
  • ▼Put/call 0.14 to 1.57
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding503424+18.6%
In funds' top 10118+37.5%
Held by funds73.2%75.3%−2.0 pts
New / increased122 / 166126 / 146+5.9%
Reduced / sold out150 / 38108 / 56+14.6%
Put/call ratio1.570.14+1038.4%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CORT institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

CORT Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$3.3M1 buy · 1 insider
Sold$98.4M51 sales · 11 insiders
93% of the selling was under pre-arranged trading plans.
2025-12 sold $6.8M2026-01 sold $704K2026-02 sold $817K2026-03 bought $3.3M2026-03 sold $2.0M2026-04 sold $819K2026-05 sold $8.3M2026-06 sold $12.6M2026-07 sold $17.6M2026-08 sold $27.0M2026-09 sold $11.6M2026-10 sold $6.2M2026-11 sold $3.6MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 13James N WilsonDirectorSale plan10,000$72.67$727K
Nov 10Daniel N Swisher JRDirectorSale plan1,500$74.07$111K
Nov 3Sean MaduckSee RemarksSale plan25,000$81.85$2.0M
Nov 2Roberto Wandenkolk VieiraPresident, OncologySale plan8,333$80.89$674K
Oct 15James N WilsonDirectorSale plan10,000$114.81$1.1M
Oct 2Sean MaduckSee RemarksSale plan25,000$116.26$2.9M
Every insider buy and sale for CORT over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See CORT insider trades →

From SEC Form 4 filings by CORT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CORT is in one of them and how their past CORT trades turned out.

CORT in the AI portfolios
Loading…

CORT News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CORT in an article yet. Here's the latest on the wider market.

CORT in the news

About Corcept Therapeutics

Corcept Therapeutics is a pharmaceutical company based in Redwood City, California, that develops medicines acting on the hormone cortisol. Its main product is Korlym, along with a generic version of it, used to treat hypercortisolism, also called Cushing's syndrome. The company sells these products in the United States through sales representatives who call on physicians treating patients with the condition. It is also testing cortisol-related drug candidates for other conditions, including some cancers, ALS and a liver disease.

Headquarters
Redwood City, CA
Founded
1998